«There is a need for sophisticated and accurate forecasting software tools that incorporate precision cancer care. Technology and artificial intelligence, in particular, have the potential to improve clinical decision-making.»

«Breast cancer affects around 1 in 8 women in the U.S. Although early detection efforts have resulted in decreased mortality rates, therapy selection remains complex. While this is partly due to the heterogeneous nature of the disease, in recent years, we have seen a significant rise in the number of therapeutic drugs approved to treat cancer patients. This creates added complexity in determining which patients will benefit most from selected treatments.»

Article written by Anu Antony



Medcity News